Irritable Bowel Syndrome

SAN ANTONIO — In this exclusive video perspective from the American College of Gastroenterology Annual Meeting, Magnus Simrén, MD, PhD, of the University of Gothenburg in Sweden, discusses the study he presented on human milk oligosaccharides as treatment for irritable bowel syndrome.

SAN ANTONIO — In this exclusive video from the American College of Gastroenterology Annual Meeting, Mark Pimentel, MD, executive director of the Medically Associated Science and Technology (MAST) program at Cedars-Sinai, discusses his presentation on the role of the gut microbiome in irritable bowel syndrome.

SAN ANTONIO — Recent opioid use was an independent risk factor for rectal hyposensitivity and defecation dysfunction in patients with chronic constipation, according to study results presented at the American College of Gastroenterology Annual Meeting.

SAN ANTONIO – At this year’s American College of Gastroenterology Annual Meeting, Healio honored Disruptive Innovators in seven different categories.

Fecal microbiota transplantation is an effective treatment for patients with irritable bowel syndrome, but the fecal sample must come from a “super donor,” according to study results presented at UEG Week.

A group of commonly used drug categories have a significant impact on the makeup of the gut microbiome, which could increase the risk for infection, obesity and other conditions, according to study results presented at UEG Week.

Over the past few years, more and more options have become available to treat irritable bowel syndrome.

By the time a patient with irritable bowel syndrome gets to a tertiary referral physician like me, they have likely tried a lot of treatments.

In my clinic, it still feels like we get countless referrals for irritable bowel syndrome.

More than 30 million people in the United States have irritable bowel syndrome.